摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(2,3-dimethylphenyl)pyridine

中文名称
——
中文别名
——
英文名称
3-(2,3-dimethylphenyl)pyridine
英文别名
——
3-(2,3-dimethylphenyl)pyridine化学式
CAS
——
化学式
C13H13N
mdl
——
分子量
183.253
InChiKey
QIPSOUAPRKVLPW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    12.9
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为产物:
    描述:
    3-氯吡啶 、 (2,3-dimethylphenyl)zinc chloride 在 tris(dibenzylideneacetone)dipalladium (0) 、 2-二环己基磷-2',6'-二异丙氧基-1,1'-联苯 作用下, 以 四氢呋喃 为溶剂, 反应 15.0h, 以100%的产率得到3-(2,3-dimethylphenyl)pyridine
    参考文献:
    名称:
    根岸交叉偶联反应的极活性催化剂
    摘要:
    已经开发了一种新的催化剂体系,用于 Pd 催化的有机锌试剂与芳基卤化物的交叉偶联(Negishi 偶联)。该系统允许有效制备受阻联芳基化合物(三和四邻位取代),在低催化剂水平下有效发挥作用,并能耐受广泛的官能团和杂环底物。对配体结构进行了系统研究,并与催化剂活性相关联。
    DOI:
    10.1021/ja0474493
点击查看最新优质反应信息

文献信息

  • Synthesis and α-adrenergic and I1-imidazoline activity of 3-phenylpiperidines dimethyl-substituted on the phenyl ring
    作者:Bruno Macchia、David B. Bylund、Vincenzo Calderone、Gino Giannaccini、Antonio Lucacchini、Marco Macchia、Adriano Martinelli、Enrica Martinotti、Elisabetta Orlandini、Federico Romagnoli、Armando Rossello
    DOI:10.1016/s0223-5234(99)80016-6
    日期:1998.11
    In a previous study we found that certain 3-phenylpiperidines (PPEs, 5) display a good activity at alpha(2)-adrenergic receptors (alpha(2)-AR), whereas they are completely inactive at alpha(1)-AR. The PPEs 5 are conformationally restricted analogs of the corresponding adrenergic drug with a phenylethylamine structure (PAEs, 4) in which the benzylic hydroxyl group characteristic of the adrenergic catecholamines is not present. The most interesting of the PPEs proved to be the 3-(3,4-dimethylphenyl) substituted compound (5a) which had been found to be essentially inactive at beta(1)- and beta(2)-AR. The methyl groups present on the aromatic ring of 5a are found, albeit in a different position, on the phenyl of alpha(2)-adrenergic agonists with arylimidazolidine and arylimidazole structures. As such PPE 5a provided a unique template for the design of alpha(2)-AR ligands. On the basis of these premises, we synthesized all the possible dimethylphenyl-substituted isomers of PPE 5a. Their activity on alpha(1)- and alpha(2)-AR and on I-1-imidazoline receptors (IR) was evaluated in vitro both by radioligand binding assays and by functional tests on isolated preparation. Two selected PPEs, 5a and 5f, were also tested for their affinity on alpha(2)-AR subtypes. Conformational studies were carried out by means of theoretical calculations, in order to rationalise the results of pharmacological tests at the molecular level. (C) Elsevier, Paris.
  • COT MODULATORS AND METHODS OF USE THEREOF
    申请人:Gilead Sciences, Inc.
    公开号:US20170008873A1
    公开(公告)日:2017-01-12
    The present disclosure relates generally to modulators of Cot (cancer Osaka thyroid) and methods of use and manufacture thereof.
  • US9815818B2
    申请人:——
    公开号:US9815818B2
    公开(公告)日:2017-11-14
  • An Extremely Active Catalyst for the Negishi Cross-Coupling Reaction
    作者:Jacqueline E. Milne、Stephen L. Buchwald
    DOI:10.1021/ja0474493
    日期:2004.10.1
    A new catalyst system for the Pd-catalyzed cross-coupling of organozinc reagents with aryl halides (Negishi coupling) has been developed. This system permits efficient preparation of hindered biaryls (tri- and tetra-ortho-substituted), functions effectively at low levels of catalyst, and tolerates a wide range of functional groups and heterocyclic substrates. A systematic study of ligand structure
    已经开发了一种新的催化剂体系,用于 Pd 催化的有机锌试剂与芳基卤化物的交叉偶联(Negishi 偶联)。该系统允许有效制备受阻联芳基化合物(三和四邻位取代),在低催化剂水平下有效发挥作用,并能耐受广泛的官能团和杂环底物。对配体结构进行了系统研究,并与催化剂活性相关联。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-